Oral Oncology
Volume 38, Issue 8 , Pages 772-778 , December 2002

Expression of β-catenin in rat oral epithelial dysplasia induced by 4-nitroquinoline 1-oxide

  • Kazumichi Sato

      Affiliations

    • Department of Oral Medicine, Tokyo Dental College, 5-11-13 Sugano, Ichikawa City, Chiba 272-8513, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-47-322-0151; fax: +81-47-324-8577
    • ,
  • Yuichiro Okazaki

      Affiliations

    • Department of Oral Medicine, Tokyo Dental College, 5-11-13 Sugano, Ichikawa City, Chiba 272-8513, Japan
    • ,
  • Morio Tonogi

      Affiliations

    • Department of Oral Medicine, Tokyo Dental College, 5-11-13 Sugano, Ichikawa City, Chiba 272-8513, Japan
    • ,
  • Yoichi Tanaka

      Affiliations

    • Division of Surgical Pathology, Clinical Laboratory, Ichikawa General Hospital, Tokyo Dental College 5-11-13 Sugano, Ichikawa City, Chiba 272-8513, Japan
    • ,
  • Gen-yuki Yamane

      Affiliations

    • Department of Oral Medicine, Tokyo Dental College, 5-11-13 Sugano, Ichikawa City, Chiba 272-8513, Japan

Received 27 May 2002 ,Accepted 14 June 2002.

References 

  1. Speight PM, Morgan PR. The natural history and pathology of oral cancer and precancer. Community Dent Health. 1993;10(Suppl 1):31–41
  2. Imai FL, Uzawa K, Shiiba M, Watanabe T, Miya T, Kubosawa H, et al. Evidence of multi-step oncogenesis of oral squamous cell carcinoma. Oncol Rep. 1998;5(6):1489–1491
  3. Okazaki Y, Yamane G, Tonogi M, Tanaka Y. Investigation of environmental factors for diagnosing malignant potential in oral epitherial dysplasia. Oral Oncol 2002;38(6):42–53.
  4. Takaki T. Cell proliferation in the carcinogenic process of tongue carcinoma in rats induced by 4-nitroquinoline-1-oxide. 2. Relation between morphology microvascular architecture and cell proliferation in keratinized lesions and squamous cell carcinoma. Shikwa Gakuho. 1986;86(5):777–804
  5. Ohne M, Satoh T, Yamada S, Takai H. Experimental tongue carcinoma of rats induced by oral administration of 4-nitroquinoline 1-oxide (4NQO) in drinking water. Oral Surg Oral Med Oral Pathol. 1985;59(6):600–607
  6. Osugi Y. p53 expression in various stages of 4-nitroquinoline 1-oxide induced carcinoma in the rat tongue. J Osaka Dent Univ. 1996;30(1–2):29–35
  7. Polakis P. Wnt signaling and cancer. Genes Dev. 2000;14(15):1837–1851
  8. Lo Muzio L. A possible role for the WNT-1 pathway in oral carcinogenesis. Crit Rev Oral Biol Med. 2001;12(2):152–165
  9. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 1997;16(13):3797–3804
  10. Morn PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 1997;275(5307):1787–1790
  11. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of cMYC as a target of the APC pathway. Science. 1998;281(5382):1509–1512
  12. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin Dl in colon carcinoma cells. Nature. 1999;398(6726):422–426
  13. Iwao K, Nakamori S, Kameyama M, Imaoka S, Kinoshita M, Fukui T, et al. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res. 1998;58(5):1021–1026
  14. Iwamoto M, Ahnen DJ, Franklin WA, Maltzman TH. Expression of beta-catenin and full-length APC protein in normal and neoplastic colonic tissues. Carcinogenesis. 2000;21(11):1935–1940
  15. Shinohara A, Yokoyama Y, Wan X, Takahashi Y, Mori Y, Takami T, et al. Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix. Gynecol Oncol. 2001;82(3):450–455
  16. Murata M, Miyoshi Y, Ohsawa M, Shibata K, Ohta T, Imai Y, et al. Accumulation of beta-catenin in the cytoplasm and the nuclei during the early hepatic tumorigenesis. Hepatol Res. 2001;21(2):126–135
  17. Bian YS, Osterheld MC, Bosman FT, Fontolliet C, Benhattar J. Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagus. Am J Clin Pathol. 2000;114(4):583–590
  18. Takahashi M, Mutoh M, Kawamori T, Sugimura T, Wakabayashi K. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis. 2000;21(7):1319–1327
  19. Tsujiuchi T, Tsutsumi M, Sasaki Y, Murata N, Konishi Y. Mutations of adenomatous polyposis coli and beta-catenin genes during progression of lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine in rats. Cancer Res. 2000;60(23):6611–6616
  20. Yamada Y, Yoshimi N, Hirose Y, Matsunaga K, Katayama M, Sakata K, et al. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res. 2001;61(5):1874–1878
  21. Lo Muzio L, Staibano S, Pannone G, Grieco M, Mignogna MD, Cerrato A, et al. Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res. 1999;19(5B):3817–3826
  22. Pukkila MJ, Virtaniemi JA, Kumpulainen EJ, Pirinen RT, Johansson RT, Valtonen HJ, et al. Nuclear beta catenin expression is related to unfavourable outcome in oropharyngeal and hypophaiyngeal squamous cell carcinoma. J Clin Pathol. 2001;54(1):42–47
  23. Suzui M, Ushijima T, Dashwood RH, Yoshimi N, Sugimura T, Mori H, et al. Frequent mutations of the rat beta-catenin gene in colon cancers induced by methylazoxymethanol acetate plus 1-hydroxyanthraquinone. Mol Carcinog. 1999;24(3):232–237
  24. Bukholm IK, Nesland JM, Borresen-Dale AL. Re-expression of E-cadherin, aipha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients. J Pathol. 2000;190(1):15–19
  25. Polakis P. The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta. 1997;1332(3):F127–F147
  26. Liu W, Dong X, Mai M, Seelan RS, Taniguchi K, Krishnadath KK, et al. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet. 2000;26(2):146–147
  27. Suzui M, Sugie S, Mori H, Okuno M, Tanaka T, Moriwaki H. Different mutation status of the beta-catenin gene in carcinogeninduced colon, brain, and oral tumors in rats. Mol Carcinog. 2001;32(4):206–212

PII: S1368-8375(02)00044-1

doi: 10.1016/S1368-8375(02)00044-1

Oral Oncology
Volume 38, Issue 8 , Pages 772-778 , December 2002

Article Tools

* Image Usage & Resolution